103 related articles for article (PubMed ID: 551896)
1. The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies.
Hicks PE
Clin Exp Hypertens (1978); 1979; 1(6):713-31. PubMed ID: 551896
[TBL] [Abstract][Full Text] [Related]
2. Changes in vascular reactivity in experimental hypertensive animals following treatment with indapamide.
Finch L; Hicks PE; Moore RA
J Pharm Pharmacol; 1977 Dec; 29(12):739-43. PubMed ID: 22620
[No Abstract] [Full Text] [Related]
3. Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet.
Biagini G; Zoli M; Torri C; Boschi S; Vantaggiato G; Ballestri M; Baraldi A; Agnati LF
Clin Sci (Lond); 1997 Nov; 93(5):401-11. PubMed ID: 9486085
[TBL] [Abstract][Full Text] [Related]
4. Modification of the antihypertensive effect of indapamide by indomethacin.
Pasnani JS; Gulati OD; Hemavathi KG
Indian J Physiol Pharmacol; 1989; 33(3):146-50. PubMed ID: 2592038
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
Suzuki H; Kondo K; Saruta T
Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
[TBL] [Abstract][Full Text] [Related]
6. [Antihypertensive and diuretic effects of indapamide in normotensive and hypertensive rats (author's transl)].
Morishita S; Nishimura K; Kato E; Shirahase H; Osumi S; Kitao K; Seki T
Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):137-46. PubMed ID: 7084816
[TBL] [Abstract][Full Text] [Related]
7. Effects of indapamide on the mechanical properties of the arterial wall in deoxycorticosterone acetate-salt hypertensive rats.
Levy BI; Poitevin P; Safar ME
Am J Cardiol; 1990 May; 65(17):28H-32H. PubMed ID: 2330906
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive profile of cicletanine, a furopyridine derivative: comparison with captopril, indapamide and prazosin.
Malherbe E; Auguet M; Delaflotte S; Le Hégarat M; Baranes J; Clostre F; Braquet P
Pharmacol Res Commun; 1988 Sep; 20 Suppl 3():121-33. PubMed ID: 2976170
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
Tsuda K; Masuyama Y
Am J Hypertens; 1991 Jan; 4(1 Pt 1):68-71. PubMed ID: 2007000
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive action of indapamide. Comparative studies in several experimental models.
Kyncl J; Oheim K; Seki T; Solles A
Arzneimittelforschung; 1975 Oct; 25(10):1491-5. PubMed ID: 1243026
[TBL] [Abstract][Full Text] [Related]
11. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
Katholi RE; Naftilan AJ; Bishop SP; Oparil S
Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
[TBL] [Abstract][Full Text] [Related]
12. Indapamide improves flow-induced dilation in hypertensive rats with a high salt intake.
Matrougui K; Lévy BI; Schiavi P; Guez D; Henrion D
J Hypertens; 1998 Oct; 16(10):1485-90. PubMed ID: 9814620
[TBL] [Abstract][Full Text] [Related]
13. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Giulumian AD; Pollock DM; Clarke N; Fuchs LC
Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
[TBL] [Abstract][Full Text] [Related]
14. Carotid artery mechanical properties of Dahl salt-sensitive rats.
Benetos A; Bouaziz H; Albaladejo P; Guez D; Safar ME
Hypertension; 1995 Feb; 25(2):272-7. PubMed ID: 7843778
[TBL] [Abstract][Full Text] [Related]
15. KCl inhibits hypothalamic activity to attenuate hypertension in DOCA-salt rats.
Sasaki S; Takeda K; Takahashi H; Yoneda S; Okajima H; Iyoda I; Yoshimura M; Ijichi H
Jpn Circ J; 1984 Nov; 48(11):1251-9. PubMed ID: 6502916
[TBL] [Abstract][Full Text] [Related]
16. Role of the antiglucocorticoid RU 486 in the prevention of steroid-induced hypertension.
Opoku J; Kalimi M
Acta Endocrinol (Copenh); 1992 Sep; 127(3):258-61. PubMed ID: 1414152
[TBL] [Abstract][Full Text] [Related]
17. Retardation of the development of hypertension in DOCA salt rats by taurine supplement.
Inoue A; Takahashi H; Lee LC; Sasaki S; Kohno Y; Takeda K; Yoshimura M; Nakagawa M
Cardiovasc Res; 1988 May; 22(5):351-8. PubMed ID: 3191519
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects of chicken extract against deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Okui T; Ono H; Kiso Y; Tanaka T
Biol Pharm Bull; 2001 Oct; 24(10):1181-4. PubMed ID: 11642328
[TBL] [Abstract][Full Text] [Related]
19. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat.
Katholi RE; Naftilan AJ; Oparil S
Hypertension; 1980; 2(3):266-73. PubMed ID: 6993358
[TBL] [Abstract][Full Text] [Related]
20. Dependence of deoxycorticosterone/salt hypertension in the rat on the activity of adrenergic cardiac nerves.
Bell C; McLachlan EM
Clin Sci (Lond); 1979 Aug; 57(2):203-10. PubMed ID: 38942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
